LEP-F1 + GLA-SE

BIOLOGICAL2 trials

Sponsors

Access to Advanced Health Institute (AAHI), The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Conditions

Leprosy

Phase 1

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

CompletedNCT03302897

Access to Advanced Health Institute (AAHI)Leprosy

Start: 2017-10-02End: 2019-03-05Updated: 2019-04-11

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)Leprosy

Start: 2024-02-29End: 2025-04-30Target: 142Updated: 2023-06-13